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Elevating care through discovery
Implementation of Stroke Pathways to Reduce Length of Stay, Cost, 
Readmissions, and Mortality
Jayme Strauss, RN, MSN, MBA, SCRN, Daniel Hartnett, RN, MSN, SCRN, Peter De Armas, RN, MSN, SCRN, Albert Fernandez, RN, BSN, SCRN, Felipe De Los Rios 
La Rosa, MD, Kunal Patel, MS, Amy Starosciak, Ph.D., Andrew Waisbrot, RN, MSN, SCRN, Starlie C. Belnap, Ph.D., Daniel D’Amour, RN, BSN, CEN, SCRN 
OBJECTIVE
To reduce length of stay (LOS) and variable cost per
case for stroke cases on a Neuroscience unit in a
community Comprehensive Stroke Center using
standardized, evidence-based clinical pathways.
BACKGROUND
Acute stroke is a major contributor to healthcare costs. In
2012, estimated direct costs associated with stroke were
$71B, which is projected to double to $184B by 2030. As
healthcare evolves and reimbursements decrease, cost
control in disease specific populations is critical. In
November 2017, length of stay (LOS) peaked at 5.78
days, as did variable and total cost/case (Table 1). In
fiscal year 2017 the 30-d readmission rate was 9% and
the mortality rate was 12%. Compliance with stroke
admission order sets was at 55%.
METHODS
A multidisciplinary committee was formed in 02/2017 to
develop standardized, evidence-based clinical pathways
for three populations:
• Ischemic stroke (IS) treated with IV t-PA
• TIA/IS without IV t-PA
• Intracerebral hemorrhage
The team met biweekly to standardize clinical pathways,
decrease time to follow-up imaging, focus on physician
order set utilization, and control costs. The stroke
pathways were implemented in 11/2017. Pathways are
discussed daily in stroke and rapid discharge rounds to
ensure compliance and identify opportunities for
improvement.
RESULTS
We reviewed a retrospective financial report of all in-
hospital cases coded as MS-DRG 61-69 from 12/2017
through 9/30/2019 and compared it the 11/2017 report
for LOS (LOS) (Fig. 1), case mix index (CMI) (Fig. 2),
variable and total costs per case (Fig.3),
readmissions (Fig.4), and mortality (Fig. 5).
Figure 3. Total (A) and Variable (B) cost/case per 
month and by Nov 2017*
RESULTS
• There was a 26% reduction in LOS (4.34 days)
• A  24% ($5,958) reduction in variable cost per case
• 6% reduction the 30-d readmission rate, and a 4%
reduction in mortality rate.
• Case mix index was 12% higher at 1.3272 (vs. 1.2055
previously)
• Order set compliance improved to 94%
• All of these improvements resulted in a realized total
cost savings of $4.5 million.
CONCLUSIONS
Standardization of stroke clinical pathways led to
improved order set compliance, almost ¼ reduction in
variable and total costs per case, shortened LOS, and
reduced mortality and readmission rates compared to the
first month after implementation of stroke pathways.
Figure 1. Monthly and 
Nov 2017 ALOS* 
Figure 2. Monthly and 
Nov 2017 CMI*
Figure 4. Quarterly 
and by Nov 2017
readmission rate* 
Figure 5. Quarterly 
and by Nov 2017 
mortality rate* 
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*Limitation: All variables were compared to a single 1-month time point as opposed to a
more prolonged period.
